Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA Advisory Committee recommends approval of Ligand's Panretin Gel

Nov. 19, 1998

Mercian presents HIV protease inhibitors produced by fungus

Nov. 19, 1998

NIAID reports important reduction in latently infected cell pool in patients on HAART + IL-2

Nov. 18, 1998

DuPont Pharma selects second-generation NNRTIs for clinical development

Nov. 17, 1998

Double protease inhibitor therapy incorporating amprenavir effective in HIV-positive patients

Nov. 17, 1998

BioStratum's novel viral vaccine protects against AIDS in animal model; company forms subsidiary

Nov. 17, 1998

First clinical results published for HIV fusion inhibitor

Nov. 12, 1998

Ciba Vision launches Vitravene in the U.S.

Nov. 10, 1998

Licensing opportunity from NIH: G-protein-coupled receptor antagonists

Nov. 5, 1998

European research group focuses on TTD non-nucleoside reverse transcriptase inhibitors

Nov. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...